4.6 Article

Deciphering the Molecular Machinery-Influence of sE-Cadherin on Tumorigenic Traits of Prostate Cancer Cells

Related references

Note: Only part of the references are listed.
Article Oncology

European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer

G. Carioli et al.

Summary: The research predicts a continued decline in cancer mortality in the EU in 2021, with an increase in female lung cancer rates. Pancreatic cancer, breast cancer, and some other cancers are expected to decrease, but attention is needed on pancreatic cancer, which shows significant declines in young men.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity

Yunhee Lee et al.

Summary: TMEM52B has been identified as a novel gene expressed widely in normal human tissues. Suppression of TMEM52B in colon cancer cells leads to enhanced epithelial-mesenchymal transition (EMT), invasion, and survival, potentially through multiple signaling pathways. Clinical data suggest that high TMEM52B expression is associated with increased patient survival in various types of cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Novel Strategies for Treating Castration-Resistant Prostate Cancer

David Ka-Wai Leung et al.

Summary: The management of castration-resistant prostate cancer has seen significant progress, with three novel hormonal agents showing survival benefits in non-metastatic patients and a wider range of management options being investigated for metastatic disease.

BIOMEDICINES (2021)

Article Medicine, Research & Experimental

Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells

Junsuke Uwada et al.

Summary: In 3D-cultured prostate cancer cells, probenecid demonstrated pleiotropic effects such as chemosensitization, growth suppression, inhibition of spheroid compaction, and suppression of anchorage-independent growth. Elucidating the detailed mechanism underlying these probenecid actions could result in the identification of novel therapeutic targets toward the advanced prostate cancer.

LIFE SCIENCES (2021)

Review Urology & Nephrology

Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates

MaryBeth B. Culp et al.

EUROPEAN UROLOGY (2020)

Article Oncology

Discussion of Treatment Options for Metastatic Hormone Sensitive Prostate Cancer Patients

Samantha S. Sigurdson et al.

FRONTIERS IN ONCOLOGY (2020)

Article Oncology

sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro

Igor Tsaur et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)

Article Cell Biology

Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness

Valentina Bizzarro et al.

CELL ADHESION & MIGRATION (2017)

Article Biochemistry & Molecular Biology

Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells

Lipsa Das et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2017)

Review Oncology

Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer

Qi-Ping Hu et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Article Oncology

sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients

Igor Tsaur et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

Soluble E-cadherin: more than a symptom of disease

Magdalena M. Grabowska et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2012)

Article Surgery

Clinical Significance of Serum Soluble E-cadherin in Colorectal Carcinoma

Yoshinaga Okugawa et al.

JOURNAL OF SURGICAL RESEARCH (2012)

Article Biochemical Research Methods

Profiling Protein Markers Associated with Lymph Node Metastasis in Prostate Cancer by DIGE-based Proteomics Analysis

Jun Pang et al.

JOURNAL OF PROTEOME RESEARCH (2010)

Review Oncology

Soluble cadherins as cancer biomarkers

Olivier De Wever et al.

CLINICAL & EXPERIMENTAL METASTASIS (2007)